Showing results (401-410 of 587) with videos related to

Sort By:
Pageof 59
Clinical Lymphoma, Myeloma & Leukemia|September 21, 2023
Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden HospitalSu Li, Bhupinder Sharma, Siraj Yusuf, et al.
BMC Cancer|April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trialsMairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2014
Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumoursTim Meyer, Wendi Qian, Martyn E Caplin, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2026
The clinical relevance of regional lymph node microarchitecture in oesophageal cancer patients - Results from the UK MRC OE02 trialMaximilian Kloft, Elzbieta Budginaite, Henry C Woodruff, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 17, 2025
Characteristics of Ipsilateral Corticomotor Pathways in People with cervical spinal cord InjuryJia Liu, Madeline Cantu, Kyle O'Laughlin, et al.
Lancet (London, England)|April 26, 2013
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cyclesDavid Cunningham, Eliza A Hawkes, Andrew Jack, et al.
ESMO Open|February 22, 2020
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised studyDavid Lau, Eleftheria Kalaitzaki, David N Church, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 3, 2022
Cost and clinical benefit of imaging surveillance after treatment for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)Rachel L O'Connell, Bhupinder Sharma, Liza Van Kerckhoven, et al.
The American Journal of Cardiology|September 28, 2015
Comparative survival after transapical, direct aortic, and subclavian transcatheter aortic valve implantation (data from the UK TAVI registry)Georg M Fröhlich, Paul D Baxter, Christopher J Malkin, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 20, 2021
DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastasesMihaela Rata, Khurum Khan, David J Collins, et al.
Pageof 59